期刊文献+

血脂异常与胃肠道息肉发生的关系研究进展

Research progress on the correlation between dyslipidemia and gastrointestinal polyp occurrence
下载PDF
导出
摘要 胃肠道息肉是指黏膜上皮或腺体过度增生形成的良性肿瘤,既可单发亦可多发,是胃肠道的癌前病变,也是消化内科的常见病。血脂异常是指人体血液中胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白(LDL)等脂类物质出现的异常状态,是一种与肥胖高度相关的代谢紊乱。近年来,关于胃肠道息肉受代谢性因素影响的研究较多,根据文献报道,大部分胃肠道息肉患者都存在血脂异常的现象,由此可以推测合理使用降脂药物对于胃肠道息肉患者有一定的预防作用。然而在各种研究中,究竟哪种脂类成分与息肉的发病有关,目前尚无定论。本文拟从血脂异常与胃肠道息肉发病的关系入手,重点探讨血脂异常和胃肠道息肉之间潜在发病机制、与胃肠道息肉的相关性以及降脂药物在胃肠道息肉中的应用等方面的研究进展进行综述。为临床上更早筛选出胃肠道息肉并及时阻断其发展提供参考。 Gastrointestinal polyp refers to a benign tumor formed by excessive hyperplasia of mucosal epithelium or glands,which can be single or multiple.It is a precancerous lesion of gastrointestinal tract and a common disease in gastroenterology.Dyslipidemia refers to the abnormal state of cholesterol(TC),triglyceride(TG)and low density lipoprotein(LDL)in human blood,which is a metabolic disorder highly associated with obesity.In recent years,there have been many researches on gastrointestinal polyps impacted by metabolic factors.According to literature reports,most patients with gastrointestinal polyps have dyslipidemia,from which we can infer that rational use of lipid-lowering drugs has a certain preventive effect on patients with gastrointestinal polyps.However,in various research,there is currently no consensus on which lipid component is related to the pathogenesis of polyps.Starting with the correlation between dyslipidemia and gastrointestinal polyp occurrence,the potential pathogenesis between dyslipidemia and gastrointestinal polyps,the correlation with gastrointestinal polyps,and the application of lipid-lowering drugs in gastrointestinal polyps and other research progresses were investigated,focused and reviewed on this paper.Some clinical reference for screening gastrointestinal polyps earlier and blocking their development in time are provided.
作者 王一朗 杨文颖 周姝妤 WANG Yilang;YANG Wenying;ZHOU Shuyu(Changchun University of Chinese Medicine,Jilin,Changchun 130117,China;Jilin Province People’s Hospital,Jilin,Changchun 130117,China)
出处 《中国医药科学》 2024年第16期41-44,共4页 China Medicine And Pharmacy
关键词 胃肠道息肉 血脂异常 降脂药物 相关性 Gastrointestinal polyps Dyslipidemia Lipid-lowering drugs Co rrelation
  • 相关文献

参考文献16

二级参考文献115

  • 1许岸高,姜泊,钟旭辉,余志金,刘集鸿.广东地区近20年大肠癌临床特征的变化趋势[J].中华医学杂志,2006,86(4):272-275. 被引量:86
  • 2赵旭东,吴娜,张薇.胆汁酸在结直肠癌发生中的研究进展[J].现代医药卫生,2006,22(22):3440-3441. 被引量:8
  • 3姚蓝,宋家武.肠息肉发生的细胞和分子生物学研究进展[J].世界华人消化杂志,2006,14(30):2958-2961. 被引量:19
  • 4Health Quality Ontario. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis[J]. Ont Health Technol Assess Ser, 2009,9:1-40. 被引量:1
  • 5Kirkegaard H, Johnsen NF, Christensen J, et al. Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study[J]. BMJ, 2010,341(c5504). 被引量:1
  • 6Jacobs R, Voorneveld P, Kodach L, et al. Cholesterol metabolism and colorectal cancers[J]. Curr Opin Pharmacol, 2012,12:690-695. 被引量:1
  • 7Pendyala S, Neff LM, Suarez-Farinas M, et al. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis[J]. Am J Clin Nutr, 2011,93:234-242. 被引量:1
  • 8Esposito K, Chiodini P, Colao A, et al. Metabolic syndrome and risk of cancer: A systematic review and meta-analysis[J]. Diabetes Care, 2012,35:2402-2411. 被引量:1
  • 9Gorin A, Gabitova L, Astsaturov I. Regulation of cholesterol biosynthesis and cancer signaling[J]. Curr Opin Pharmacol, 2012,12:710-716. 被引量:1
  • 10van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition[J]. Gut, 2011,60:1094-1102. 被引量:1

共引文献1307

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部